VC demonstrated a benign safety profile, with no serious safety concerns reported.
from: Evaluation of the effectiveness of Vernonia cinerea for the treatment of smoking cessationNon-serious adverse effects included mild and transient symptoms such as tongue numbness, nausea, vomiting, drowsiness, and dizziness.
from: Evaluation of the effectiveness of Vernonia cinerea for the treatment of smoking cessationNon-serious adverse effects included mild and transient symptoms such as tongue numbness, nausea, vomiting, drowsiness, and dizziness.
from: Evaluation of the effectiveness of Vernonia cinerea for the treatment of smoking cessationNon-serious adverse effects included mild and transient symptoms such as tongue numbness, nausea, vomiting, drowsiness, and dizziness.
from: Evaluation of the effectiveness of Vernonia cinerea for the treatment of smoking cessationNon-serious adverse effects included mild and transient symptoms such as tongue numbness, nausea, vomiting, drowsiness, and dizziness.
from: Evaluation of the effectiveness of Vernonia cinerea for the treatment of smoking cessationNon-serious adverse effects included mild and transient symptoms such as tongue numbness, nausea, vomiting, drowsiness, and dizziness.
from: Evaluation of the effectiveness of Vernonia cinerea for the treatment of smoking cessationThere was no clear benefit of VC compared to nicotine replacement therapy or nortriptyline.